LexaGene Holdings Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q1 2022 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
LexaGene Holdings Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q1 2022 to Q4 2022.
  • LexaGene Holdings Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending November 30, 2022 was $51.6K.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $51.6K Nov 30, 2022 10-Q 2023-01-17
Q3 2022 $24.8K Aug 31, 2022 10-Q 2022-10-18
Q1 2022 $14.4K Feb 28, 2022 10-Q 2023-01-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.